权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Core 2: Lung Tissue Core

核心2：肺组织核心

基本信息

批准号：
10262934
负责人：
Mauricio Rojas
金额：
$ 13.87万
依托单位：
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
依托单位国家：
美国
项目类别：
财政年份：
2011
资助国家：
美国
起止时间：
2011-09-01 至 2023-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10262934
关键词：
3-Dimensional Address Age Animal Model Animals Autopsy Biological Biological Models Biomechanics Bone Marrow Bone Marrow Stem Cell Cells Clinical Data Clinical Trials Collaborations Collection Comparative Study Complex Consultations DNA Disease Distal Endothelial Cells Epithelial Cells Evaluation Fibroblasts Genomics Goals Histopathology Housing Human Individual Infection Inflammation Institution Investigation Knowledge Lung Lung Transplantation Mesenchymal Stem Cells Modeling Molecular Mus Organ Organ Culture Techniques Organ Donor Organ Procurements Pathogenesis Pathology Pathway interactions Patients Perfusion Pharmacotherapy Population Proteins Protocols documentation Pulmonary artery structure RNA Research Research Personnel Research Project Grants Resources Role Sampling Sepharose Skin Smooth Muscle Myocytes Source Specimen Standardization Structure of parenchyma of lung System Systemic Scleroderma Techniques Testing Therapeutic Therapeutic Intervention Time Tissue Embedding Tissue Model Tissue Sample Tissues Translational Research Transplant Recipients Transplantation Trauma Universities base biobank design efficacy testing ex vivo perfusion experimental study hemodynamics human disease human model improved mouse model novel novel therapeutics pre-clinical preclinical study programs pulmonary function response stem cells synergism systemic inflammatory response therapeutic candidate therapeutic evaluation tool translational model translational study vertebra body

项目摘要

Core 002 - Abstract In this revised version we had actualize the role of lung tissue core and the numbers of samples collected. This core will be compromise by three centralized subcores, each of which is essential to reach the goals of this program application. The Core includes, a bio-bank sub- core collecting biological samples from patients and organ donors through the University of Pittsburgh, an ex-vivo lung perfusion sub-core, to study lung function, pathology, and hemodynamics of lungs maintained under ex-vivo perfusion, and an ex-vivo 3-D human lung tissue model sub-core, to generate sections of lung tissue that can be culture for long periods of time. All three components are essential for the mechanistic and translational research goals of this Program application. The Specific Aims for the Core are: 1. To enrich our current biorepository of lung, skin and bone marrow stem cells procured from normal individuals and individuals with SSc. 2. To assist program investigators in the design and implementation of experiments using biological specimens from the biobank. Research Plan: The bio-bank will provide tissue samples of lung, skin and bone marrow stem cells procured from normal individuals and individuals with SSc. We will include the collection of lung and skin fibroblasts, bone marrow derived stem cells, endothelial cells, and smooth muscle cells, as well as tissue samples for RNA, DNA, protein and histopathology analyses. The ex-vivo lung perfusion sub-core will provide a preclinical translational model for the test of therapeutic candidates. The ex-vivo 3-D human lung tissue model sub-core will provide a collection of pulmonary arteries for biomechanical analyses, and agarose embedded tissue for ex-vivo 3D lung organ culture. Significance and synergy: Comparative studies between human and mice of responses to systemic inflammation demonstrate marked differences and poor correlations between the two species, confirming the difficulties in the use of animal models to mimic human diseases. There is a need of more preclinical studies using human specimens to answer fundamental questions in complex diseases such as systemic sclerosis. All Research Projects will use resources of the lung tissue core to: 1) test mechanistic hypotheses of the pathogenesis of SSc, 2) test the efficacy of new therapeutics in established ex vivo lung perfusion model and 3-D human lung tissue model, and 3) evaluate molecular mechanisms in human biological samples.

Core 002 -摘要